Michaela Jonsson Nordvall
Publications
2026
Adaptation of the molecular bacterial load assay for real-time quantification of Mycobacterium tuberculosis in the clinical routine laboratory
Microbiology Spectrum
(Article in journal)
https://dx.doi.org/10.1128/spectrum.01018-26
Differential Regulation of Oxidative Burst by First Line Drugs Used Against Multi Drug-Resistant Tuberculosis in Naïve Human Innate Immune Cells
Antibiotics, Vol. 15, Article 590
(Article in journal)
https://dx.doi.org/10.3390/antibiotics15060590
2022
Safety and pharmacokinetics-pharmacodynamics of a shorter tuberculosis treatment with high-dose pyrazinamide and rifampicin: a study protocol of a phase II clinical trial (HighShort-RP)
BMJ Open, Vol. 12, Article e054788
(Article in journal)
https://dx.doi.org/10.1136/bmjopen-2021-054788
2021
Genotypic resistance of pyrazinamide but not MIC is associated with longer time to sputum culture conversion in patients with multidrug-resistant tuberculosis
Clinical Infectious Diseases, Vol. 73, p. E3511-E3517
(Article in journal)
https://dx.doi.org/10.1093/cid/ciaa1509
2020
A novel mycobacterial growth inhibition assay employing live-cell imaging of virulent M. tuberculosis and monitoring of host cell viability
Tuberculosis, Vol. 124, Article 101977
(Article in journal)
https://dx.doi.org/10.1016/j.tube.2020.101977